2006 Oncology Nursing Drug Handbook is a comprehensive nursing resource for assessment, intervention, and patient education in the administration of oncology drugs. This text reviews drug information from the nurse's point of view, and helps the nurse focus on minimizing toxicity. This essential reference provides valuable information on effective symptom management and chemotherapy administration for the oncology nurse. Updated annually, the 2006 edition includes the following new drugs: four antineoplastic agents (clofarabine, histrelin implant, paclitaxel protein bound particles for injection, TLK 286), four antimicrobial agents (micafungin, rifaximin, gemifloxacin, tigecycline), two immunotherapy/biotherapy symptom management agents (Imiquimod 5% cream., palifermin), and eight molecularly targeted drugs (lapatanib, panitumumab, pertuzumab, sorafeni (BAY 43-9006), sunitinib malate (sutent, SU11246), temsirolimus, tipifarnib, vatalanib), and one symptom management drug (ziconotide intrathecal infusion). In addition, indications and additional toxicity data have been updated for individual drugs, such as bevacizumab, cetuximab, and gefitinib.
This text for beginning and advanced oncology nurses integrates the nursing process, including nursing diagnosis, with the administration of cancer chemotherapeutic agents. Chapters in the first section review the history of chemotherapy and the role of the oncology nurse in chemotherapy research. The second, main part of the text presents drug information forms and nursing care plans for more than 80 drugs. Each care plan includes a table of nursing diagnoses, defining characteristics, expected outcomes, and nursing interventions related to that drug. Finally, technical procedures for administration and safe handling of anti-neoplastic agents are discussed. c. Book News Inc.
Written especially for nurses caring for patients with cancer, the 2014 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.
Written Expressly For Nurses Caring For Patients With Cancer, The 2009 Oncology Nursing Drug Handbook Uniquely Expresses Drug Therapy In Terms Of The Nursing Process: Nursing Diagnoses, Etiologies Of Toxicities, And Key Points For Nursing Assessment, Intervention, And Evaluation. An Essential Reference Updated Annually, The Text Provides Valuable Information On Effective Symptom Management, Patient Education, And Chemotherapy Administration. Completely Revised And Updated, The 2009 Oncology Nursing Drug Handbook Includes: - New, Administered Drugs: Amrubicin, Patupilone; Levoleucovorin, Dexrazoxane For Injection (Extravasation), Casopitant, Fosaprepitant, Granisetron Hcl Transdermal, Desvenlafaxine, Denosumab, Methlnaltrexone Bromide - Drug Updates For Bendamustine And Ixapapilone - Specific Drugs Are Described In Terms Of Their Mechanism Of Action, Metabolism, Drug Interactions, Laboratory Effects/Interference, And Special Considerations. The Most Important And Common Drug Side Effects Are Also Discussed.
This book supplements other oncology nursing textbooks and provides hands-on information to assist the nurse in providing comprehensive care to patients receiving chemotherapy and to their families. The focus of the text is on the chemotherapeutic agents, their side effects, the corresponding nursing diagnoses and care plans, and states methods of administration andhandling of these drugs.
Written especially for nurses caring for patients with cancer, the 2015 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2015 Oncology Nursing Drug Handbook includes a simplified chapter on molecular and biological targeted therapy that incorporates new information about immunotherapy, new indications, and the most important and common side effects. New drug entries include: afatinib, belinostat, ceritinib, ibrutinib, idelalisib, obinutuzumab, pembrolizumab, ramucirumab, siltuximab, and mercaptopurine oral suspension.
Important Notice: The digital edition of this book is missing some of the images or content found in the physical edition. Written especially for nurses caring for patients with cancer, the 2013 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2013 Oncology Nursing Drug Handbook includes: * New drug entries and revisions * Specific drugs described in terms of their mechanism of action, metabolism, drug interactions, laboratory effects/interference, and special considerations * The most important and common drug side effects * Greater discussion of fundamentals of malignant transformation, new molecular targets, and drugs in the pipeline
Written especially for nurses caring for patients with cancer, the 2018 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2018 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs.
This issue of the Nursing Clinics of North America focuses on the expanding knowledge of oncology nursing. The science of cancer, the disease, is expanding at an unprecedented pace producing knowledge that is unparalleled in its complexity. Nurses caring for oncology patients require specialized knowledge to care for their patients safely. The articles in this edition include cutting-edge information written by authors who practice in corresponding settings. The articles are devoted to Oncology Genomics: Implications for Oncology/Cancer Nurses; Informatics; Evidence-Based Practice in Oncology Nursing; Brain Cancer and Family Caregiving; Symptom Management and Palliative Care for Patients with Cancer; Lung Cancer and Tobacco: What’s New; Health Disparities; Changes in Cancer Treatment: Nibs and Mabs; Clinical Trials and the Role of the Oncology Clinical Research Nurse Cancer Survivorship; and Oral Chemotherapeutic Agents.
Written expressly for nurses caring for patients with cancer, the 2010 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. An essential reference updated annually, the text provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2010 Oncology Nursing Drug Handbook includes: New and updated administered drugs. Specific drugs are described in terms of their mechanism of action, metabolism, drug interactions, laboratory effects/interference, and special considerations. The most important and common drug side effects are discussed.
Written especially for nurses caring for patients with cancer, the 2016 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation.
A new and updated version of this best-selling resource! Jones and Bartlett Publisher's 2011 Nurse's Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference! It provides: Accurate, timely facts on hundreds of drugs from abacavir sulfate to Zyvox; Concise, consistently formatted drug entries organized alphabetically; No-nonsense writing style that speaks your language in terms you use everyday; Index of all generic, trade, and alternate drug names for quick reference. It has all the vital information you need at your fingertips: Chemical and therapeutic classes, FDA pregnancy risk category and controlled substance schedule; Indications and dosages, as well as route, onset, peak, and duration information; Incompatibilities, contraindications; interactions with drugs, food, and activities, and adverse reactions; Nursing considerations, including key patient-teaching points; Vital features include mechanism-of-action illustrations showing how drugs at the cellular, tissue, or organ levels and dosage adjustments help individualize care for elderly patients, patients with renal impairment, and others with special needs; Warnings and precautions that keep you informed and alert.
Written expressly for nurses caring for patients with cancer, the 2012 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.Completely revised and updated, the 2012 Oncology Nursing Drug Handbook includes:* New drug entries and revisions* Specific drugs described in terms of their mechanism of action, metabolism, drug interactions, laboratory effects/interference, and special considerations* The most important and common drug side effects* Greater discussion of fundamentals of malignant transformation, new molecular targets, and drugs in the pipeline
This comprehensive book and CD-ROM learning package is designed for the oncology nurse preparing for certification and/or recertification. The text is organized according to the eight areas tested on the Oncology Certification Exam. The Fourth Edition is completely updated with new questions and revised to reflect changes that have been made to the OCN exam. The companion CD-ROM includes practice questions that can be rearranged and customized to create a new exam over and over.
2007 Oncology Nursing Drug Handbook is a comprehensive nursing resource for assessment, intervention, and patient education in the administration of oncology drugs. This text reviews drug information from the nurse's point of view, and helps the nurse focus on minimizing toxicity. This essential reference provides valuable information on effective symptom management and chemotherapy administration for the oncology nurse. Revised annually with new drugs, the book also includes updated indications and additional toxicology data for individual drugs.
The second edition of Oncology Nursing Drug Reference is updated with the most current drugs including topotecan, irinotecan, gemcitabine, docetaxel, and many other newly approved oncology drugs. Wilkes continues to offer definitive, easy-to-access drug information for the oncology nurse. With new content on cytoprotectants, investigational agents, and bone marrow transplantation, 1997-1998 Oncology Nursing Drug Handbook provides a comprehensive reference for assessment, intervention, and education related to cancer drug therapy.
Written especially for nurses caring for patients with cancer, the 2020-2021 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2018 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs.
Written especially for nurses caring for patients with cancer, the 2017 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2017 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs. New drugs include: alectin
This pocket-sized, clinical reference provides the most pertinent information from Cancer Nursing: Principles and Practice, ed. Susan L. Groenwald. In outline format, the text covers the subject areas of the epidemiologic and pathophysiologic aspects of cancer, emergency treatment modalities and diagnostics, the management of common symptoms and of patients with 26 system- or location-specific types of cancer, delivery systems for cancer care, cancer survival, and professional issues. Annotation copyrighted by Book News, Inc., Portland, OR
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.